• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多粘菌素B包裹的银纳米颗粒对多重耐药鲍曼不动杆菌的体外抗炎及拮抗功效

In-vitro anti-inflammatory and antagonistic efficacy of polymyxin B capped silver nanoparticles in multi drug resistant Acinetobacter baumannii.

作者信息

Siddiqui Fatima, Zahra Nureen, Amjad Muhammad Faisal, Zeshan Basit, Alam Rabail, Jaffar Hafiza Madiha, Aziz Tariq, Alshehri Fatma, Al-Asmari Fahad, Al-Joufi Fakhria A, Alwethaynani Maher S, Baothman Bandar K

机构信息

Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, 54000, Punjab, Pakistan.

Department of Biotechnology, GC University, Lahore, 54000, Punjab, Pakistan.

出版信息

Sci Rep. 2025 May 20;15(1):17465. doi: 10.1038/s41598-025-01639-2.

DOI:10.1038/s41598-025-01639-2
PMID:40394110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12092596/
Abstract

Multidrug resistant Acinetobacter baumannii is declared as crucial level precedence pathogen by World Health Organization that needs new and upgraded antibiotics for better treatment. Against a vast extent of microbes, many silver nanoparticles have displayed anti-microbial activity because of their numerous methods of antimicrobial actions. This study was aimed to isolate and characterize the Acinetobacter baumannii by using standard microbiological technique and to analyze the anti-inflammatory and antagonistic effect of PB capped AgNPs in isolated A. baumannii. In antagonistic activity, PB capped AgNPs showed antagonistic effect in 8 out of 20 isolates tested and PB when combined with AgNPs showed antagonistic effect in all isolates tested. In in-vitro anti-inflammatory egg albumin assay, PB capped AgNPs gave inhibition rate of 96% at 12.5 µg, 93% at 25 µg, 82% at 50 µg and 62% at 100 µg whereas in Polymyxin B combined AgNPs it gave inhibition rate of 97% at the dose of 50 µg. In-silico analysis also showed that PB in combination with tri-sodium citrate gave good binding energy than tri-sodium citrate and Polymyxin used alone. Hence, this study represented that silver nanoparticles when used in combination proved to be a good alternative in the treatment of MDR Acinetobacter baumannii.

摘要

多重耐药鲍曼不动杆菌被世界卫生组织列为关键优先级别病原体,需要新型和升级的抗生素来进行更好的治疗。由于其多种抗菌作用方式,许多银纳米颗粒对多种微生物都显示出抗菌活性。本研究旨在通过标准微生物技术分离和鉴定鲍曼不动杆菌,并分析聚丁二炔包覆的银纳米颗粒(PB capped AgNPs)对分离出的鲍曼不动杆菌的抗炎和拮抗作用。在拮抗活性方面,在测试的20株菌株中,聚丁二炔包覆的银纳米颗粒对8株显示出拮抗作用,而聚丁二炔与银纳米颗粒联合使用时对所有测试菌株均显示出拮抗作用。在体外抗炎蛋清蛋白测定中,聚丁二炔包覆的银纳米颗粒在12.5微克时抑制率为96%,25微克时为93%,50微克时为82%,100微克时为62%,而在多粘菌素B联合银纳米颗粒中,在50微克剂量时抑制率为97%。计算机模拟分析还表明,聚丁二炔与柠檬酸三钠联合使用时的结合能比单独使用柠檬酸三钠和多粘菌素时更好。因此,本研究表明,银纳米颗粒联合使用被证明是治疗多重耐药鲍曼不动杆菌的一种良好替代方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/e695b253c1f6/41598_2025_1639_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/2e2d7c17f016/41598_2025_1639_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/6a2ce3b485f3/41598_2025_1639_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/6e5801098fdc/41598_2025_1639_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/3edea59d36b4/41598_2025_1639_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/482fe26f33d0/41598_2025_1639_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/69c505112c0c/41598_2025_1639_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/09db054ead61/41598_2025_1639_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/f0ebe06dcc6f/41598_2025_1639_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/f6667aa7a41b/41598_2025_1639_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/b1fd1d999c58/41598_2025_1639_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/c094a2718545/41598_2025_1639_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/5dd7bac5e1f5/41598_2025_1639_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/4a3ad039aca2/41598_2025_1639_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/b73063c0a0b2/41598_2025_1639_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/e5f65b23f8ab/41598_2025_1639_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/520efbfeb96f/41598_2025_1639_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/d5b9d999d6a0/41598_2025_1639_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/e695b253c1f6/41598_2025_1639_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/2e2d7c17f016/41598_2025_1639_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/6a2ce3b485f3/41598_2025_1639_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/6e5801098fdc/41598_2025_1639_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/3edea59d36b4/41598_2025_1639_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/482fe26f33d0/41598_2025_1639_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/69c505112c0c/41598_2025_1639_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/09db054ead61/41598_2025_1639_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/f0ebe06dcc6f/41598_2025_1639_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/f6667aa7a41b/41598_2025_1639_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/b1fd1d999c58/41598_2025_1639_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/c094a2718545/41598_2025_1639_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/5dd7bac5e1f5/41598_2025_1639_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/4a3ad039aca2/41598_2025_1639_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/b73063c0a0b2/41598_2025_1639_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/e5f65b23f8ab/41598_2025_1639_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/520efbfeb96f/41598_2025_1639_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/d5b9d999d6a0/41598_2025_1639_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bca/12092596/e695b253c1f6/41598_2025_1639_Fig18_HTML.jpg

相似文献

1
In-vitro anti-inflammatory and antagonistic efficacy of polymyxin B capped silver nanoparticles in multi drug resistant Acinetobacter baumannii.多粘菌素B包裹的银纳米颗粒对多重耐药鲍曼不动杆菌的体外抗炎及拮抗功效
Sci Rep. 2025 May 20;15(1):17465. doi: 10.1038/s41598-025-01639-2.
2
Efflux pump inhibitory activity of biologically synthesized silver nanoparticles against multidrug-resistant Acinetobacter baumannii clinical isolates.生物合成银纳米粒子对多重耐药鲍曼不动杆菌临床分离株外排泵抑制活性的研究。
J Basic Microbiol. 2020 Jun;60(6):494-507. doi: 10.1002/jobm.201900712. Epub 2020 Apr 17.
3
Green synthesis of silver nanoparticles using Acroptilon repens aqueous extract and their antibacterial efficacy against multidrug-resistant Acinetobacter baumannii.利用顶羽菊水提取物绿色合成银纳米颗粒及其对多重耐药鲍曼不动杆菌的抗菌效果
Mol Biol Rep. 2024 Dec 12;52(1):47. doi: 10.1007/s11033-024-10156-w.
4
Biogenic silver nanoparticle (Bio-AgNP) has an antibacterial effect against carbapenem-resistant Acinetobacter baumannii with synergism and additivity when combined with polymyxin B.生物成因银纳米粒子(Bio-AgNP)对耐碳青霉烯鲍曼不动杆菌具有抗菌作用,与多黏菌素 B 联合使用时具有协同作用和相加作用。
J Appl Microbiol. 2022 Feb;132(2):1036-1047. doi: 10.1111/jam.15297. Epub 2021 Sep 28.
5
Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii.银纳米颗粒对抗多重耐药鲍曼不动杆菌的抗生物膜和抗病毒活力潜力。
Sci Rep. 2021 May 24;11(1):10751. doi: 10.1038/s41598-021-90208-4.
6
Antibiofilm effect of biogenic silver nanoparticle alone and combined with polymyxin B against carbapenem-resistant Acinetobacter baumannii.生物合成银纳米颗粒单独及联合多黏菌素 B 对碳青霉烯类耐药鲍曼不动杆菌的抗生物膜效应。
Braz J Microbiol. 2024 Sep;55(3):2789-2796. doi: 10.1007/s42770-024-01438-3. Epub 2024 Jul 18.
7
Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii.银纳米粒子联合抗生素对耐药菌鲍曼不动杆菌的影响。
Int J Nanomedicine. 2016 Aug 12;11:3789-800. doi: 10.2147/IJN.S104166. eCollection 2016.
8
Study of MIC of silver and zinc oxide nanoparticles, strong and cost-effective antibacterial against biofilm-producing Acinetobacter baumannii in Shiraz, Southwest of Iran.伊朗西南部设拉子市产生物膜鲍曼不动杆菌的强效、经济抗菌纳米银和氧化锌的 MIC 研究。
BMC Infect Dis. 2024 Jun 17;24(1):593. doi: 10.1186/s12879-024-09471-1.
9
Trimethyl chitosan-capped silver nanoparticles with positive surface charge: Their catalytic activity and antibacterial spectrum including multidrug-resistant strains of Acinetobacter baumannii.具有正表面电荷的三甲基壳聚糖包覆银纳米颗粒:它们的催化活性和抗菌谱,包括鲍曼不动杆菌的多重耐药菌株。
Colloids Surf B Biointerfaces. 2017 Jul 1;155:61-70. doi: 10.1016/j.colsurfb.2017.03.054. Epub 2017 Apr 1.
10
Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.抗蠕虫药氯氰碘柳胺增强多粘菌素B对多重耐药鲍曼不动杆菌的杀菌作用。
J Antibiot (Tokyo). 2016 Jun;69(6):415-21. doi: 10.1038/ja.2015.127. Epub 2015 Dec 16.

本文引用的文献

1
Drug-Drug Interactions in Nosocomial Infections: An Updated Review for Clinicians.医院感染中的药物相互作用:临床医生最新综述
Pharmaceutics. 2024 Aug 28;16(9):1137. doi: 10.3390/pharmaceutics16091137.
2
Antivirulence activities of Rutin-loaded chitosan nanoparticles against pathogenic Staphylococcus aureus.芦丁载壳聚糖纳米粒抗致病性金黄色葡萄球菌的抗毒力活性。
BMC Microbiol. 2024 Sep 7;24(1):328. doi: 10.1186/s12866-024-03446-7.
3
Retracted: Vancomycin as an Antibacterial Agent Capped with Silver Nanoparticles: An Experimental Potential Analysis.
撤回:载银纳米颗粒的万古霉素作为抗菌剂:实验潜力分析。
Biomed Res Int. 2024 Jan 9;2024:9784637. doi: 10.1155/2024/9784637. eCollection 2024.
4
Evaluation of the Anti-inflammatory, Antimicrobial, Antioxidant, and Cytotoxic Effects of Chitosan Thiocolchicoside-Lauric Acid Nanogel.壳聚糖硫代秋水仙碱-月桂酸纳米凝胶的抗炎、抗菌、抗氧化及细胞毒性作用评估
Cureus. 2023 Sep 26;15(9):e46003. doi: 10.7759/cureus.46003. eCollection 2023 Sep.
5
Development of Nanoparticle Adaptation Phenomena in Acinetobacter baumannii: Physiological Change and Defense Response.鲍曼不动杆菌中纳米颗粒适应现象的发展:生理变化与防御反应。
Microbiol Spectr. 2023 Feb 14;11(1):e0285722. doi: 10.1128/spectrum.02857-22. Epub 2023 Jan 10.
6
Effects of amikacin, polymyxin-B, and sulbactam combination on the pharmacodynamic indices of mutant selection against multi-drug resistant .阿米卡星、多粘菌素B和舒巴坦联合用药对耐多药菌突变选择药效学指标的影响
Front Microbiol. 2022 Oct 20;13:1013939. doi: 10.3389/fmicb.2022.1013939. eCollection 2022.
7
In vitro analysis of synergistic combination of polymyxin B with 12 other antibiotics against MDR Acinetobacter baumannii isolated from a Chinese tertiary hospital.多粘菌素B与其他12种抗生素联合对一株来自中国某三级医院的多重耐药鲍曼不动杆菌的体外协同分析
J Antibiot (Tokyo). 2023 Jan;76(1):20-26. doi: 10.1038/s41429-022-00573-z. Epub 2022 Oct 28.
8
Antimicrobial susceptibility to polymyxin B and other comparators against Gram-negative bacteria isolated from bloodstream infections in China: Results from CARVIS-NET program.中国从血流感染中分离出的革兰氏阴性菌对多粘菌素B及其他对照抗菌药物的敏感性:CARVIS-NET项目的结果
Front Microbiol. 2022 Oct 6;13:1017488. doi: 10.3389/fmicb.2022.1017488. eCollection 2022.
9
Ciprofloxacin-Loaded Silver Nanoparticles as Potent Nano-Antibiotics against Resistant Pathogenic Bacteria.负载环丙沙星的银纳米颗粒作为对抗耐药病原菌的强效纳米抗生素
Nanomaterials (Basel). 2022 Aug 16;12(16):2808. doi: 10.3390/nano12162808.
10
Antibacterial activity of silver nanoparticles against carbapenem-resistant Acinetobacter baumannii clinical isolates.银纳米粒子对碳青霉烯类耐药鲍曼不动杆菌临床分离株的抗菌活性。
Pak J Pharm Sci. 2022 Jan;35(1(Supplementary)):203-208.